Loading...

ZHNG

ZYBT

ZHENGYE BIOTECHNOLOGY HOLDING LTD

(ZYBT)

2025 6-K

Nasdaq Deficiency Notice

4 Jun '26

Annual Meeting Results

24 Mar '26

Annual Meeting Notice

27 Feb '26

Director Resignation

23 Feb '26

Financial Report Submission

12 Dec '25

NASDAQ Delinquency Notice

23 May '25

New Company Formation

2 Apr '25

CEO Appointment

6 Mar '25

IPO Over-allotment

14 Jan '25

IPO Announcement

8 Jan '25

External Links:

SEC

On January 13, 2025, Zhengye Biotechnology Holding Ltd. reported that Kingswood Capital Partners fully exercised an over-allotment option for 225,000 shares at $4.00 each, raising total proceeds to $6.9 million from its IPO.

AI Assistant

ZHENGYE BIOTECHNOLOGY HOLDING LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.